Literature DB >> 3042736

Influenza infection causes airway hyperresponsiveness by decreasing enkephalinase.

D B Jacoby1, J Tamaoki, D B Borson, J A Nadel.   

Abstract

Ferret tracheal segments were infected with human influenza virus A/Taiwan/86 (H1N1) in vitro. After 4 days, the smooth muscle contractile responses to acetylcholine and to substance P were measured. The response to substance P was markedly accentuated, with a threefold increase in force of contraction at a substance P concentration of 10(-5) M, the highest concentration tested. In contrast, the response to acetylcholine was not affected by viral infection. Histological examination of tissues revealed extensive epithelial desquamation. Activity of enkephalinase (neutral metallo-endopeptidase, EC.3.4.24.11), an enzyme that degrades substance P, was decreased by 50% in infected tissues. Inhibiting enkephalinase activity by pretreating with thiorphan (10(-5) M) increased the response to substance P to the same final level in both infected and control tissues. Inhibiting other substance P-degrading enzymes including kininase II (angiotensin-converting enzyme), serine proteases, and aminopeptidases did not affect the response to substance P. Inhibiting cyclooxygenase and lipoxygenase activity using indomethacin and BW 755c did not affect hyperresponsiveness to substance P. Pretreating tissues with antagonists of alpha-adrenoceptors, beta-adrenoceptors, and H1 histamine receptors (phentolamine 10(-5) M, propranolol 5 X 10(-6) M, and pyrilamine 10(-5) M, respectively) had no effect on substance P-induced contraction. These results demonstrate that infection of ferret airway tissues with influenza virus increases the contractile response of airway smooth muscle to substance P. This effect is caused by decreased enkephalinase activity in infected tissues.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3042736     DOI: 10.1152/jappl.1988.64.6.2653

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  40 in total

1.  Effect of neutral endopeptidase inhibitor on airway function and bronchial responsiveness in asthmatic subjects.

Authors:  G M Nichol; B J O'Connor; J M Lecomte; K F Chung; P J Barnes
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Decreased neutral endopeptidases: possible role in inflammatory diseases of airways.

Authors:  J A Nadel
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 3.  Mechanisms of virus induced exacerbations of asthma.

Authors:  J M Corne; S T Holgate
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

Review 4.  Why do viruses make infants wheeze?

Authors:  I M Balfour-Lynn
Journal:  Arch Dis Child       Date:  1996-03       Impact factor: 3.791

5.  Effect of respiratory tract viral infection on murine airway beta-adrenoceptor function, distribution and density.

Authors:  P J Henry; P J Rigby; J S Mackenzie; R G Goldie
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

6.  [Role of nasal sinus infections in the pathogenesis of allergic and inflammatory diseases].

Authors:  P Van Cauwenberge; J B Watelet
Journal:  Rev Fr Allergol Immunol Clin       Date:  2005-05-16

7.  The effect of anticholinergic bronchodilator therapy on cough during upper respiratory tract infections.

Authors:  R Lowry; A Wood; T Higenbottam
Journal:  Br J Clin Pharmacol       Date:  1994-02       Impact factor: 4.335

8.  Functional effects of phosphoramidon and captopril on exogenous neuropeptides in human nasal mucosa.

Authors:  C Châtelain; N Pochon; J S Lacroix
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

9.  Endogenous tachykinins facilitate transmission through parasympathetic ganglia in guinea-pig trachea.

Authors:  N Watson; J Maclagan; P J Barnes
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

10.  The pH of activation of the hemagglutinin protein regulates H5N1 influenza virus replication and pathogenesis in mice.

Authors:  Hassan Zaraket; Olga A Bridges; Charles J Russell
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.